Evidence map›Paper›PMID 39392007›Full record

ArticleCirculation2025

YAP Overcomes Mechanical Barriers to Induce Mitotic Rounding and Adult Cardiomyocyte Division.

Yuka Morikawa, Jong H Kim, Rich Gang Li, Lin Liu, Shijie Liu, Vaibhav Deshmukh, Matthew C Hill, James F Martin

Abstract read
In one paragraph

Article in Circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Mechanisms and Therapeutic Potential of Human Cardiomyocyte Proliferation.Journal of cardiovascular development and disease · 2026
    Review
  7. Review
  8. Gene therapy CM-YAPNature cardiovascular research · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Dysfunctional cardiomyocyte signalling and heart disease.Current opinion in cell biology · 2025
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yuka MorikawaCardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (Y.M., J.H.K., R.G.L., L.L., S.L., J.F.M.).ORCID 0000-0002-4571-8409
Jong H KimCardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (Y.M., J.H.K., R.G.L., L.L., S.L., J.F.M.).ORCID 0000-0002-4491-212X
Rich Gang LiCardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (Y.M., J.H.K., R.G.L., L.L., S.L., J.F.M.).ORCID 0000-0001-9661-8304
Lin LiuCardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (Y.M., J.H.K., R.G.L., L.L., S.L., J.F.M.).
Shijie LiuCardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (Y.M., J.H.K., R.G.L., L.L., S.L., J.F.M.).
Vaibhav DeshmukhDepartment of Integrative Physiology (V.D., J.F.M.), Baylor College of Medicine, Houston, TX.ORCID 0000-0002-0087-7545
Matthew C HillCardiovascular Research Center, Massachusetts General Hospital, Boston (M.C.H.).ORCID 0000-0003-4578-3873
James F MartinCardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (Y.M., J.H.K., R.G.L., L.L., S.L., J.F.M.).ORCID 0000-0002-7842-9857

Funding

MULTIDISCIPLINARY RESEARCH TRAINING IN CARDIOLOGYT32HL007208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Patrick Thomas Ellinor, David E Sosnovik · 1985 to 2026
$16.1M
Pitx2 in atrial fibrillationR01HL118761 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MARTIN, JAMES F · 2014 to 2025
$6.1M
Hippo and Wnt Signaling in Cardiac RegenerationR01HL127717 · NHLBI · TEXAS HEART INSTITUTE · PI MARTIN, JAMES F · 2016 to 2023
$4.4M
Optical elastography for assessment of myocardial regenerationR01HL130804 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LARIN, KIRILL V, MARTIN, JAMES F · 2016 to 2019
$2.9M
Cytoskeletal Control of Yap in Heart RegenerationR01HL169511 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI James F Martin · 2023 to 2026
$2.7M
Reawakening cardiomyocyte proliferation from structural mediated quiescenceR01HL171574 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI James F Martin, Sean M Wu · 2024 to 2026
$1.9M
COMPLEMENT IN THE CELLULAR MICROENVIRONMENT DURING CARDIAC RENEWALK99HL174827 · NHLBI · TEXAS HEART INSTITUTE · PI LI, RICH GANG · 2024 to 2025
$194k
NHLBI NIH HHS K99 HL174827NHLBI NIH HHS R01 HL118761NHLBI NIH HHS R01 HL127717NHLBI NIH HHS R01 HL130804NHLBI NIH HHS R01 HL169511NHLBI NIH HHS R01 HL171574NHLBI NIH HHS T32 HL007208
6 · The paper itself

Abstract

backgroundMany specialized cells in adult organs acquire a state of cell cycle arrest and quiescence through unknown mechanisms. Our limited understanding of mammalian cell cycle arrest is derived primarily from cell culture models. Adult mammalian cardiomyocytes, a classic example of cell cycle arrested cells, exit the cell cycle postnatally and remain in an arrested state for the life of the organism. Cardiomyocytes can be induced to re-enter the cell cycle by YAP5SA, an active form of the Hippo signaling pathway effector YAP.

methodsWe performed clonal analyses to determine the cell cycle kinetics of YAP5SA cardiomyocytes. We also performed single-cell RNA sequencing, marker gene analysis, and functional studies to examine how YAP5SA cardiomyocytes progress through the cell cycle.

resultsWe discovered that YAP5SA-expressing cardiomyocytes divided efficiently, with >20% of YAP5SA cardiomyocyte clones containing ≥2 cardiomyocytes. YAP5SA cardiomyocytes re-entered cell cycle at the G1/S transition and had an S phase lasting ≈48 hours. Sarcomere disassembly is required for cardiomyocyte progression from S to G2 phase and the induction of mitotic rounding. Although oscillatory Cdk expression was induced in YAP5SA cardiomyocytes, these cells inefficiently progressed through G2 phase. This is improved by inhibiting P21 function, implicating checkpoint activity as an additional barrier to YAP5SA-induced cardiomyocyte division.

conclusionsOur data reveal that YAP5SA overcomes the mechanically constrained myocardial microenvironment to induce mitotic rounding with cardiomyocyte division, thus providing new insights into the in vivo mechanisms that maintain cell cycle quiescence in adult mammals.

Indexed as

Adaptor Proteins, Signal TransducingMitosisMyocytes, CardiacYAP-Signaling ProteinsAnimalsCell Cycle ProteinsCell DivisionCells, CulturedMiceSarcomeresSignal TransductionTranscription FactorsAdaptor Proteins, Signal TransducingCell Cycle ProteinsTranscription FactorsYap1 protein, mouseYAP-Signaling Proteinscell cycleHippo pathwaymitotic roundingmyocyte proliferationP21sarcomere disassemblyYAP

Identifiers

PMID39392007
PMCPMC11671297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.